MOQC Update

Douglas Blayney, MDPhysician Lead, MOQC

Transforming Oncology Care Together

MOQC RECOGNITION

Transforming Oncology Care Together

Improving Extravasation Management Working Group

• Allegiance Health Hematology & Oncology• Cancer & Hematology Centers of Western

Michigan • Karmanos Cancer Institute• Sparrow Regional Cancer Center• University of Michigan Cancer Center• West Michigan Cancer Center

Annual Competency Assessment Tools Working Group

• Toledo Clinic Hematology Oncology• West Michigan Cancer Center

Improving Symptom Management Quality Initiative

• Southwest Michigan Oncology Associates• St. John Lymphoma Clinic • St. John Health Partners – Great Lakes Cancer

Management Specialists

QOPI Certified Practices

• Sparrow Regional Cancer Center• Toledo Clinic Hematology Oncology• Northern Michigan Hematology Oncology• West Michigan Cancer Center• Southwest Michigan Oncology Associates• University of Michigan Cancer Center

QOPI Certified Practices

NEW IN FALL 2012Five New Practices!!

Marquette General Hematology / Oncology ChippewaEscanabaHancockMarquette North Country

MOQC OVERALL PERFORMANCE

Transforming Oncology Care Together

Infertility Risks & Preservation Options Not DocumentedInfertility Risks & Preservation Options Not Documented

Pal Care Demo 1

Pal Care Demo 1

Pal Care Demo 1

Pain Initiative

Palliative Care Demonstration Project Initial Results

IMPROVING PERFORMANCE ON HOSPICE AND PALLIATIVE CARE REFERRALS AND

DISCUSSIONS QOPI MEASURE:

IDENTIFYING BARRIERS AND COUNTERMEASURES Transforming Oncology Care Together

ON THE HORIZON:

Transforming Oncology Care Together

New QOPI® Test Measures: Choosing Wisely

• Breast Cancer Diagnosis (stage I, IIA, or II B)– PET, CT, or radionuclide bone scan (lower is better)

• Breast Cancer Surveillance after curative treatment– PET, CT, or radionuclide bone scan within 12 months of diagnosis

(lower is better)– Serum tumor marker surveillance within 12 months of diagnosis

(lower is better)

New QOPI® Test Measures: Choosing Wisely

• G-CSF use in metastatic– Colon cancer (lower is better)– NSCLC cancer (lower is better)– Breast cancer (lower is better)

• Chemotherapy administered to patients with metastatic solid tumor with performance status of 3,4 or undocumented ( lower is better)

New with QOPI®

Certification•Change from NHL to NSCLC module as required module to apply

eQOPI•Abstraction of measures from EHR•Different measure set than “classic QOPI”

– Look for pilot in late 2013 or early 2014

New with MOQC?QOPI Certification Mock SurveysTobacco Cessation InitiativeGoals of Care Initiative

Application will be available in late springOral Chemotherapy Initiative with MSHO Application will be available in summer

Initiatives eligible for ABIM Maintenance of Certification Part IV. Practice Performance Assessment credit designation